Cargando…
Angiographic Change After Injection of Beperminogene Perplasmid, a Hepatocyte Growth Factor Gene Therapy Product for the Treatment of Critical Limb Ischemia
Autores principales: | Kakei, Yusuke, Kimura, Masayoshi, Nagashima, Takao, Sawada, Takahisa, Matoba, Satoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811228/ https://www.ncbi.nlm.nih.gov/pubmed/35178487 http://dx.doi.org/10.1253/circrep.CR-21-0148 |
Ejemplares similares
-
Intravenous administration of human Muse cells recovers blood flow in a mouse model of hindlimb ischemia
por: Hori, Yusuke, et al.
Publicado: (2022) -
Clot regression effects of rivaroxaban in the treatment of venous thromboembolism in patients with cancer (CRERIT-VTE cancer): study protocol
por: Takai, Shigeki, et al.
Publicado: (2019) -
Acute Limb Ischemia Related to Neutrophil Extracellular Traps in a Patient With COVID-19
por: Ozawa, Takaaki, et al.
Publicado: (2022) -
Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020) -
Angiographic Lesion Morphology Provides Incremental Value to Generalize Quantitative Flow Ratio for Predicting Myocardial Ischemia
por: Zhang, Jie, et al.
Publicado: (2022)